Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland.

Détails

Ressource 1Télécharger: s41467-021-23796-4.pdf (881.47 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_9A79ABBCD2E3
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland.
Périodique
Nature communications
Auteur⸱e⸱s
Stringhini S., Zaballa M.E., Pullen N., de Mestral C., Perez-Saez J., Dumont R., Picazio A., Pennacchio F., Dibner Y., Yerly S., Baysson H., Vuilleumier N., Balavoine J.F., Bachmann D., Trono D., Pittet D., Chappuis F., Kherad O., Kaiser L., Azman A.S., Guessous I.
Collaborateur⸱rice⸱s
SEROCoV-WORK + Study Group
Contributeur⸱rice⸱s
Alber V., Arm-Vernez I., Bachmann D., Bachmann D., Baggio S., Monteiro G.B., Baysson H., Bleich P., Boissel I., Collombet P., Courvoisier D., Couson P., Davidovic A., Deiri C., Del Rio D., de Mestral C., De Ridder D., D'ippolito P., Duc J., Eckerle I., El Merjani N., Ferniot G., Flahault A., Francioli N., Frangville M., Garande C., Gétaz L., Giraldo P., Golaz F., Guérin J., Haboury L., Harnal S., Javet V., Kaiser L., Laboulais A., Lamour G., Lefebvre X., Lescuyer P., Loizeau A.J., Lombard F.B., Lorthe E., Martinez C., Massiha K., Metral-Boffod L., Meyer B., Mostaguir K., Nehme M., Noël N., Oederlin N., Petrovic D., Piumatti G., Portier J., Poulain G., Pugin C., Rakotomiaramanana B., Randrianandrasana Z.F., Richard A., Richard V., Rodriguez-Velazquez S., Salzmann-Bellard L., Thorens L., Torroni S., Vidonne D., Violot G., Waldmann Z., Will M., Wisniak A.
ISSN
2041-1723 (Electronic)
ISSN-L
2041-1723
Statut éditorial
Publié
Date de publication
08/06/2021
Peer-reviewed
Oui
Volume
12
Numéro
1
Pages
3455
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: epublish
Résumé
Limited data exist on SARS-CoV-2 infection rates across sectors and occupations, hindering our ability to make rational policy, including vaccination prioritization, to protect workers and limit SARS-CoV-2 spread. Here, we present results from our SEROCoV-WORK + study, a serosurvey of workers recruited after the first wave of the COVID-19 pandemic in Geneva, Switzerland. We tested workers (May 18-September 18, 2020) from 16 sectors and 32 occupations for anti-SARS-CoV-2 IgG antibodies. Of 10,513 participants, 1026 (9.8%) tested positive. The seropositivity rate ranged from 4.2% in the media sector to 14.3% in the nursing home sector. We found considerable within-sector variability: nursing home (0%-31.4%), homecare (3.9%-12.6%), healthcare (0%-23.5%), public administration (2.6%-24.6%), and public security (0%-16.7%). Seropositivity rates also varied across occupations, from 15.0% among kitchen staff and 14.4% among nurses, to 5.4% among domestic care workers and 2.8% among journalists. Our findings show that seropositivity rates varied widely across sectors, between facilities within sectors, and across occupations, reflecting a higher exposure in certain sectors and occupations.
Mots-clé
Adolescent, Adult, Aged, Antibodies, Viral/immunology, COVID-19/epidemiology, COVID-19/immunology, Female, Humans, Immunoglobulin G/immunology, Male, Middle Aged, Prevalence, SARS-CoV-2/immunology, Sample Size, Switzerland/epidemiology, Young Adult
Pubmed
Web of science
Open Access
Oui
Création de la notice
15/06/2021 15:44
Dernière modification de la notice
09/01/2024 8:24
Données d'usage